IMDX
NASDAQ
US
Insight Molecular Diagnostics Inc. - Common Stock
$3.76
▲ +$0.32
(+9.30%)
Vol 293K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$215.0M
ROE
-426.7%
Margin
-1380.7%
D/E
91.89
Beta
0.15
52W
$2–$9
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
70.0%
Buy Rating
Price Chart
Similar Stocks
BDTX
Black Diamond Therapeutics Inc
P/E 6.4
$138.4M
KLRS
Kalaris Therapeutics Inc
$141.3M
AGEN
Agenus Inc
$106.8M
EQ
Equillium Inc
$94.4M
HUMA
Humacyte Inc
$185.4M
PEPG
PepGen Inc
$447.6M
GNLX
Genelux Corp
$165.9M
SGMO
Sangamo Therapeutics Inc
$141.3M
BMEA
Biomea Fusion Inc
$87.7M
KPTI
Karyopharm Therapeutics Inc
$125.5M
Earnings
Beat rate: 0.0%
Next Report
May 11, 2026
EPS Estimate: $-0.27
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.27 | — | — |
| Dec 2025 | $-0.24 | $-0.72 | $-0.48 |
| Sep 2025 | $-0.21 | $-0.34 | $-0.13 |
| Jun 2025 | $-0.23 | $-0.30 | $-0.07 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -426.7% | -426.7% | -426.7% | -426.7% | -426.7% | -426.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1880.7% | -1489.7% | -1489.7% | -1489.7% | -1380.7% | -1380.7% |
| Gross Margin | 67.6% | 54.5% | 54.5% | 54.5% | 54.7% | 54.7% |
| D/E Ratio | 91.89 | 91.89 | 91.89 | 91.89 | 91.89 | 91.89 |
| Current Ratio | 4.04 | 4.04 | 4.04 | 4.04 | 2.79 | 2.79 |
Key Ratios
ROA (TTM)
-128.0%
P/S (TTM)
48.84
EPS (TTM)
$-2.83
Rev Growth 3Y
-5.1%
52W High
$8.51
52W Low
$2.33
$2.33
52-Week Range
$8.51
How does IMDX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
IMDX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
48.8
▲
280%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
IMDX profitability vs Biotechnology peers
ROE
-426.7%
▼
534%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-1380.7%
▼
381%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
54.7%
▼
30%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-128.0%
▼
174%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
IMDX financial health vs Biotechnology peers
D/E ratio
91.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
2.8
▼
37%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.2
▼
85%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
IMDX fundamentals radar
IMDX
Peer median
Industry
IMDX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IMDX vs peers: key metrics
Latest News
No related news yet